Type 1 diabetes (T1D) is an organ-specific disease characterized by the deficiency of insulin caused by the autoimmune destruction of pancreatic islet β cells. Stem cell-based therapies play essential roles

Here at Throne Biotechnologies, we are pleased to announce Dr. Theodore Mazzone, M.D., as our new chief medical officer. Dr. Mazzone has been a clinical physician, scientist, and professor for nearly

Over the last 10 years, CB-SC have been utilized in international multicenter clinical trials and designated to Stem Cell Educatorâ (SCE) therapy for the treatment of autoimmune disease including type

We are happy to announce that Throne’s Equity Crowdfunding Campaign was closed yesterday, successfully raising more than enough money to kickstart our Clinical Trials at Throne Biotechnologies (Throne). We sincerely